Educational Grants


Educational Grants

Promius® Pharma supports independent medical education programs that provide non-promotional, medical, and scientific education to health care providers (HCPs). The intent of these programs is to improve patient care through HCP education. All such programs must be compliant with applicable legal and regulatory guidelines.

Through our Educational Grant program, Promius Pharma helps address the clinical practice gaps that exist in the diagnosis, management, and prevention of certain diseases. Promius Pharma also supports patient education through educational grants to patient advocacy groups. Priority will be given to grant applications from non-profit educational, professional, and patient advocacy organizations in the healthcare field.

Therapeutic Areas of Interest for Educational Grants

The Promius Pharma Educational Grants Office will accept and review educational grant requests in the following therapeutic areas:


  • Migraine – Adult


  • Medical Dermatology

Note: For any supported non-accredited educational activity intended for healthcare providers and for education intended for patients and/or caregivers, any discussion of Promius Pharma products must be within approved product labeling and fairly balanced.

Types of Grants Considered for Funding

The Promius Pharma Educational Grants Office will consider educational grant applications that meet the following criteria:

  • Independent educational activities taking place within the United States or providing substantial educational activities applicable to US healthcare
  • CE-accredited or non-accredited, non-promotional educational activities
  • Activities scheduled to occur at least 90 days after the date of submission of a complete educational grant request
  • Activities providing significant independent, non-promotional, scientific education within Promius Pharma therapeutic areas of interest (listed above)
  • Activities held at venues appropriate for the provision of independent, non-promotional, education without significant distraction
  • Activities designed for the non-promotional education of HCPs, including physicians, medical fellows, medical residents, medical interns, medical students, nurses, physician’s assistants, pharmacists, and/or other health professionals
  • Activities whose faculty has been selected by the conference organizers completely independently of commercial sponsors
  • Activities whose educational content has been developed by the conference faculty completely independently of commercial sponsors

Types of Grants Not Considered for Funding

Promius Pharma will NOT provide medical education grants for the following:

  • Individual HCPs or HCP private practice groups
  • Health plans or managed care organizations
  • Grant requestors who have received past funding but have not adequately completed educational grant reconciliation within the specified time frame
  • Grant requestors who have received past funding but have not returned unused grant funds within the specified time frame
  • Activities that are intended to directly or indirectly promote Promius Pharma products
  • Events in which there are recreational components (for example, golf or spa activities)
  • Events which include gifts to speakers or attendees
  • Activities that have already occurred or are in process
  • Research or training within a medical institution
  • Clinical research or investigator-initiated trials
  • Charitable contributions
  • Service contracts
  • Promotional exhibit or display fees
  • Combined funding for educational and promotional activities
  • Events that do not have an educational focus
  • Professional or business development activities
  • Travel, lodging, meals, or registration for any HCP to attend a meeting or event, if that HCP is not part of the program faculty. Funding for faculty accommodation should be commensurate with the actual duration of time that the HCP is required to participate in a multi-day event.
  • Entertainment (such as recognitions, retirement dinners, holiday parties)
  • Capital or operating expenses (for example, purchase of equipment, staff salary, etc.)
  • Funding of promotional exhibits or display space
  • Journal clubs
  • Textbooks or Equipment

Guidelines and Regulations

The Promius Pharma medical education grant program is administered in accordance with the recommendations and guidance of the Office of Inspector General (OIG), Pharmaceutical Research and Manufacturers of America (PhRMA), the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: Open Payments (commonly known as the Sunshine Act), internal Promius Pharma compliance policies, and other applicable regulations and guidance.

Promius Pharma provides independent educational grants based on the scientific and educational merit of the proposed activity. No educational grants shall be provided or offered to a health care professional in exchange for prescribing products or for a commitment to continue prescribing products. Nothing should be offered or provided in a manner that would interfere with the independence of a healthcare professional’s prescribing practices or decision-making.

Prohibited Actions

  • Promius Pharma employees may not facilitate applications for educational grant funding, request or convey educational grant status information on behalf of or to applicants, or submit or review applications for educational grant funding.
  • An educational grant may never be made with the intent to induce referrals for the purchase, prescribing, dispensing, or recommending of Promius Pharma products or to influence the position of any Promius Pharma product on a managed care formulary or generic program.
  • Promius Pharma employees cannot provide any advice or guidance to an individual or organization requesting an educational grant regarding the content, faculty, educational methods, materials, venue, or any other matter related to the educational event.
  • Promius Pharma cannot directly or indirectly fund a Healthcare Professional’s travel, lodging, or personal expenses related to attending an educational event as a non-faculty participant.
  • Promius Pharma cannot directly or indirectly compensate any Healthcare Professional for attending an educational event. Educational grant funding may be used by the requesting organization to cover the costs associated with faculty participation.
  • Promius Pharma educational grant funds may not be used to provide food or beverage to attendees at educational events. However, Promius Pharma grant funding can be used to cover the costs associated with faculty participation (for example, compensation, travel, meals). If food and beverage are provided for participants at educational events supported by Promius Pharma educational grant funding, the cost for these must be covered by alternative funding or participant registration fees (ie, not Promius Pharma educational grant funding) and ACCME guidelines should be followed, in that meals should be modest and not be the primary focus of the gathering of HCPs.

Reconciliation of Completed Grants

Promius Pharma requires reconciliation of all educational grants within 90 days of the activity end date. The purpose of the reconciliation is to verify that the grant support was used in the manner in which it was intended. At the conclusion of the Promius Pharma funded activity, the grant recipient is required to submit the following information:

  • Summary of participants/audience reach
  • Evaluation data or other information to verify that grant funds were used as described in the Educational Grant application
  • Financial reconciliation
  • HCP payment Sunshine Act reporting documentation

If educational grant reconciliation is not received within 90 calendar days of the activity end date, grant support applications will not be accepted from your organization until this reconciliation has been received. Promius Pharma reserves the right to request receipts to support the activity expenses specified in the grant reconciliation.

NOTE: All unused funds must be returned to Promius Pharma within 90 days of the activity end date. Educational grant recipients are not permitted to redirect funds for purposes not specified in the original grant application.

National Physician Payment Transparency Program: Open Payments

On February 8, 2013 the Centers for Medicare & Medicaid Services (CMS) published the final rule to implement section 6002 of the Patient Protection and Affordable Care Act (Public Law No. 111-148), known as the National Physician Payment Transparency Program: Open Payments (commonly referred to as the Sunshine Act), which was revised and final rule published in the Federal Register on October 13, 2014.

Promius Pharma captures and submits to the CMS all payments and other Transfers of Value (TOV) made to physicians and Teaching Institutions (TIs) annually. Promius Pharma requires all recipients of educational grant funding to report any non-excluded TOV made to covered recipients.

Beginning in 2016, indirect payments to physicians speaking at continuing education programs accredited by one of the following: the Accreditation Council for Continuing Medical Education (ACCME); the American Academy of Family Physicians (AAFP); the American Dental Association’s Continuing Education Recognition Program (ADA CERP); the American Medical Association (AMA); or the American Osteopathic Association (AOA), must be reported to CMS if the applicable manufacturer knows or finds out the identity of the physician attendees/speakers within the reporting year or by the end of the second quarter of the following reporting year.

An indirect payment is defined as 42 C.F.R. §403.902 as a payment or other transfer of value made by an applicable manufacturer requires, instructs, direct, or otherwise causes the third party to provide the payment or transfer of value, in whole or in part, to the covered recipient.

Additional reporting is required for activities that do not meet the accreditation or certification requirements and/or standards of ACCME, AOA, AAFP, and AMA, including all indirect payments (faculty compensation, travel, meals) to all Covered Recipients associated with this activity.

The following information is required to be reported to Promius Pharma within 90 calendar days of the activity end date including, but not limited to:

  • Covered Recipient (CR) type: physician or Teaching Institution (TI)
  • CR full name
  • Complete business address
  • National Provider Identifier (NPI) number and/or license number
  • Specialty (if applicable)
  • Form of payment or transfer of value
  • Nature of payment or transfer of value

To obtain the Promius Pharma Sunshine reporting form or for questions about Sunshine Act reporting related to Promius Pharma educational grant funding, email

For questions regarding the National Physician Payment Transparency Program: Open Payments (commonly known as the Sunshine Act), please visit:

How to Apply for a Promius Educational Grant

All educational grant applications must be submitted electronically to No mailed or faxed applications will be accepted.

Educational grant applications will not be accepted for review until they are complete. When a completed application has been received, you will receive an acknowledgement containing a unique application number. Please reference this number when corresponding about your grant application.

In order to be accepted for review, complete educational grant applications must be received at least 90 days before the start of an educational activity.

Required Application Documents

A complete application package consists of the following:

  • Letter of Request on requesting organization letterhead
  • Promius Pharma Grant Certification Form signed by authorized representative of the requesting organization
  • Program description, including intended audience
  • Learning objectives and proposed agenda
  • Information describing CE accreditation and accrediting organization, if applicable
  • Budget, including the overall cost of the program and a breakout of detailed line items
  • W-9

Promius Pharma Educational Grants Form

If your grant application is approved, the authorized signer identified in your application will receive an electronic Educational Grant Agreement for review and signature.

A signed copy of this Educational Grant Agreement must be returned to Promius Pharma at the email address before the approved grant payment can be processed.

Promius Pharma does not accept 3rd party Letters of Agreement. Promius Pharma educational grant funding is contingent upon authorized signers’ execution of the Promius Pharma Educational Grant Agreement.

Disclosure of Grant Support

Promius Pharma educational grant support must be disclosed prior to the start of the supported educational activity. The disclosure should take the form: “Supported by an educational grant from Promius Pharma” or similar disclosure.

The Promius Pharma company logo will be provided upon request. Please reference your educational grant application number when requesting a copy of our company logo.

Promius Pharma reserves the right to publicly disclose the grant recipient organization name, event title and description, payee state, and grant amount awarded.

Contact Us

For questions, additional information, or submission of educational grant request materials, please use the following email address: